Clinical Trial

Study on the Medical Education Capability of the EyeTeacher Artificial Intelligence Platform

Study acronym: EyeTeacher
Not Yet Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated January 6, 2025 (before its estimated December 30, 2025 completion). Its status may not reflect the trial's current state.
Summary
With the rise of generative artificial intelligence and large language models, medical education is undergoing a significant transformation. Numerous studies have highlighted the limitations of traditional educational knowledge acquisition and the potential impact of artificial intelligence on medical education, resident training, and continuing education for clinical practitioners. However, there is a lack of real-world experiments on the effectiveness of AI-integrated education. Artificial intelligence can provide extensive educational resources and tools that are not limited by geographical location or language, thereby lowering the barrier to accessing high-quality medical education and promoting educational equity. Nevertheless, the performance of AI models trained by different medical institutions or healthcare systems may vary. To offer a more universal, accessible, high-quality, and interconnected educational journey. We have developed a virtual ophthalmology teacher, which developed based on foundational model and large language models. This model, named EyeTeacher provide comprehensive theoretical knowledge and clinical skills enhancement for untrained medical students. To verify the effectiveness of our EyeTeacher across different national ophthalmology education systems and languages, we plan to implement a randomized controlled trial. This trial will assess the clinical capabilities of all participants and explore the advantages and disadvantages of the system compared to traditional teaching methods.
Trial Details
NCT Number NCT06759012
Lead Sponsor Tsinghua University
Conditions Medical Education
Enrollment 252 participants
Start Date 2025-01-05
Primary Completion 2025-12-30 (estimated)
Study Completion 2025-12-30 (estimated)
Updated on ClinicalTrials.gov 2025-01-06